The 2020 ACC/AHA Guidelines for Management of Patients With Valvular Heart Disease: Highlights and Perioperative Implications.

Autor: Mohananey D; Division of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, WI., Aljadah M; Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee, WI., Smith AAH; Division of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, WI., Haines JF; Division of Cardiovascular Medicine, Medical College of Wisconsin, Milwaukee, WI., Patel S; Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee, WI., Villablanca P; Interventional Cardiology, Henry Ford Hospital, Detroit, MI., Ramakrishna H; Division of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN. Electronic address: Ramakrishna.harish@mayo.edu.
Jazyk: angličtina
Zdroj: Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2022 May; Vol. 36 (5), pp. 1467-1476. Date of Electronic Publication: 2021 Apr 17.
DOI: 10.1053/j.jvca.2021.04.013
Abstrakt: Valvular heart disease contributes to a large burden of morbidity and mortality in the United States. During the last decade there has been a paradigm shift in the management of valve disease, primarily driven by the emergence of novel transcatheter technologies. In this article, the latest update of the American College of Cardiology/American Heart Association valve heart disease guidelines is reviewed.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: